MEP Luis Garicano on Vaccine Approvals in Europe and Slow Vaccine Rollout

The transcript discusses the slow vaccine procurement in Europe, highlighting issues with manufacturing, approval, and distribution bottlenecks. It questions the European Commission's strategy and speculates on balancing different pharmaceutical companies. The discussion also covers the criticism of the European Medicines Agency's slow approval process compared to other countries. The need for faster vaccine approval and deployment is emphasized, with references to the success of other countries like Israel.

What are the potential consequences of delays in vaccine distribution mentioned in the text?

Evaluate responses using AI:

OFF

How does the text suggest that the European Commission should handle vaccine procurement?

Evaluate responses using AI:

OFF

What criticisms are directed at the European regulator in comparison to regulators in the UK and the US?

Evaluate responses using AI:

OFF